Cargando…
Challenges and developments in universal vaccine design against SARS-CoV-2 variants
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had become a global concern because of its unexpectedly high pathogenicity and transmissibility. SARS-CoV-2 variants that reduce the immune protection elicited from previous vaccination or natural infection raise challenge...
Autores principales: | Zhao, Fangxin, Zai, Xiaodong, Zhang, Zhiling, Xu, Junjie, Chen, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761649/ https://www.ncbi.nlm.nih.gov/pubmed/36535982 http://dx.doi.org/10.1038/s41541-022-00597-4 |
Ejemplares similares
-
RBD(206)-sc-dimer induced robust cross-neutralization against SARS-CoV-2 and variants of concern
por: Zhou, Chuge, et al.
Publicado: (2021) -
Advanced Vaccine Design Strategies against SARS-CoV-2 and Emerging Variants
por: Zhang, Jianzhong, et al.
Publicado: (2023) -
Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccination
por: Chi, Xiangyang, et al.
Publicado: (2022) -
SARS-CoV-2 vaccine challenge based on spike glycoprotein against several new variants
por: Syahniar, Rike, et al.
Publicado: (2022) -
Are the new SARS-CoV-2 variants resistant against the vaccine?
por: Abdalla, Mohnad, et al.
Publicado: (2021)